Evidence map›Paper›PMID 10639432›Full record

ArticleInfection and immunity2000

Mucosally induced immunoglobulin E-associated inflammation in the respiratory tract.

J W Simecka, R J Jackson, H Kiyono, J R McGhee

Open access · greenAbstract read
In one paragraph

Article in Infection and immunity, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
4.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

J W SimeckaDepartment of Molecular Biology and Immunology, University of North Texas Health Science Center in Fort Worth, Fort Worth, Texas 76107, USA. jsimecka@hsc.unt.edu
R J Jackson
H Kiyono
J R McGhee
University of Alabama at Birmingham · USOsaka University · JPUniversity of North Texas Health Science Center · US

Funding

MUCOSAL IMMUNIZATION RESEARCH GROUPN01AI015128 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI MCGHEE, JERRY R · 1991 to 1996
–
NIAID NIH HHS AI15128
6 · The paper itself

Abstract

The purpose of the present study was to determine the immunologic responses, particularly immunopathologic reactions, associated with nasal immunization with the mucosal adjuvant, cholera toxin (CT). BALB/c mice were nasally immunized with tetanus toxoid (TT) combined with CT, and the responses of these mice were determined. After nasal immunization, mice produce a serum antibody response, primarily of the immunoglobulin G (IgG) isotype of predominantly IgG1 subclass, against both TT and CT. Along with the antibody responses, we also found that inflammatory reactions, which could be potentially fatal, developed within the lung. Furthermore, IgE responses were also induced after nasal immunization, and these responses were associated with the detection of interleukin 5 in the serum. Thus, nasal immunization with TT plus CT likely results in the activation of Th2 cells, which may contribute to serious immunopathologic reactions in the lung.

Indexed as

Administration, IntranasalAnimalsAntibodies, BacterialCholera ToxinFemaleImmunity, MucosalImmunizationImmunoglobulin EInflammationInterleukin-5LungMiceMice, Inbred BALB CTetanus ToxoidAntibodies, BacterialCholera ToxinImmunoglobulin EInterleukin-5Tetanus Toxoid

Identifiers

PMID10639432
PMCPMC97191
OpenAlexW1966371104

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.